Back to Journals » Drug Design, Development and Therapy » Volume 15

Comparison of Pharmacokinetic, Pharmacodynamic and Tolerability Profiles of CKD-11101, Darbepoetin Alfa (NESP®) Biosimilar, to Those of NESP® After a Single Subcutaneous or Intravenous Administration to Healthy Subjects

Total article views   Abstract views HTML views PDF downloads Totals
659 Dovepress* 659 0+ 62 659
Totals 659 0 62 659
*Since 28 April 2021
+Since July 2016

View citations on Google Scholar